OPN1LW and Parkinson disease: Additionally, high predictive validity of RES as a tool to assess the efficacy of dopaminergic and non-dopaminergic drugs for both FM and Parkinson’s disease seems to be another potential limitation of our study and the effectiveness of drugs such as ROP in the RES-based Parkinson’s disease model (and FM) must be considered.